Klaus Lieb How Prevalent is Conflict of Interest in the Medical Profession?
Klaus Lieb is Chair of the Department of Psychiatry and Psychotherapy at the University Medical Center, Mainz and Managing Director of the German Resilience Center (DRZ). His main research interests include clinical resilience research and cognitive enhancement and conflicts of interest in medical practice and research. A member of the Drug Commission of the German Medical Association (DCGMA), Lieb is the author of several books including Conflicts of Interest, Corruption and Compliance in the Health Service (MWV, 2018). The recipient of a Golden Helix award in 2004, Lieb was awarded the Hamburger Prize for his work on Personality Disorders in 2013.
Area of Research
Therapy response prediction in affective disorders; Clinical resilience research and cognitive enhancement; Systematic reviews and metaanalyses; Conflicts of interests in clinic and research
since 2017
Managing Director
German Resilience Centre (Deutsches Resilienz Zentrum)
since 2014
Deputy Speaker
German Resilience Centre (Deutsches Resilienz Zentrum)
since 2007
Director and Chair
Johannes Gutenberg University Mainz (Johannes Gutenberg-Universität Mainz)
Department of Psychiatry and Psychotherapy
2001-2007
Vice Chair
Albert Ludwigs University of Freiburg (Albert-Ludwigs-Universität Freiburg)
Department of Psychiatry and Psychotherapy
1999
Habilitation and „Venia legendi“ in Psychiatry
Albert Ludwigs University of Freiburg (Albert-Ludwigs-Universität Freiburg)
Faculty of Medicine
1994-1999
Research Assistant and Junior Doctor
Albert Ludwigs University of Freiburg (Albert-Ludwigs-Universität Freiburg)
Department of Psychiatry and Psychotherapy, Department of Neurology
1992-1994
Doctor in Training and Research Assistant
University of Ulm (Universität Ulm)
Departments of Internal Medicine and Anatomy and Cell Biology
1992
Dr. med., M.D.
University of Ulm (Universität Ulm)
1985-1992
Studies of Medicine and Philosophy
University of Ulm (Universität Ulm)
& Universities of Tübingen and Los Angeles
- Editor, Cochrane Developmental, Psychosocial and Learning Problems Group (CDPLPG)
- Editor, InFo Neurologie und Psychiatrie
- Member, Arzneimittelkommission der Deutschen Ärzteschaft
Prizes
- Hochschullehrer des Jahres (Deutscher Hochschulverband, 2013)
- Hamburger Prize Personality Disorders (2013)
- Golden Helix Award (2004)
- Hormosan-Forschungspreis Psychiatrie (2003)
Allegiance to a particular form of therapy or financial ties to a pharmaceutical company are among the phenomena that can undermine a physician’s primary goal, to provide the best possible treatment for his or her patients. In this video, KLAUS LIEB explores the ways in which conflicts of interest occur for both physicians and medical researchers before providing some suggestions as to how they might be avoided. Employing methods including surveys, systematic reviews and a randomized controlled trial, Lieb finds that conflict of interest has a notable influence in several of the areas studied. Demonstrating that educating medical students about the dangers of conflict of interest can go a long way towards reducing its impact, Lieb’s work provides important food for thought for physicians, medical researchers and regulatory bodies.
LT Video Publication DOI: https://doi.org/10.21036/LTPUB10747
Medical Students’ Attitudes to and Contact with the Pharmaceutical Industry: A Survey at Eight German University Hospitals
- Klaus Lieb and Cora Koch
- Deutsches Ärzteblatt International
- Published in 2013
A Survey of German Physicians in Private Practice about Contacts with Pharmaceutical Sales Representatives
- Klaus Lieb and Simone Brandtönies
- Deutsches Ärzteblatt International
- Published in 2010
Contact Between Doctors and the Pharmaceutical Industry, their Perceptions, and the Effects on Prescribing Habits
- Klaus Lieb and Armin Scheurich
- PloS One
- Published in 2014
The Financing of Drug Trials by Pharmaceutical Companies and its Consequences: Part 1: A Qualitative, Systematic Review of the Literature on Possible Influences on the Findings, Protocols, and Quality of Drug Trials
- Gisela Schott, Henry Pachl, Ulrich Limbach, Ursula Gundert-Remy, Wolf-Dieter Ludwig and Klaus Lieb
- Deutsches Ärzteblatt International
- Published in 2010
The Financing of Drug Trials by Pharmaceutical Companies and its Consequences: Part 2: A Qualitative, Systematic Review of the Literature on Possible Influences on Authorship, Access to trial data, and Trial Registration and Publication
- Gisela Schott, Henry Pachl, Ulrich Limbach, Ursula Gundert-Remy, Klaus Lieb and Wolf-Dieter Ludwig
- Deutsches Ärzteblatt International
- Published in 2010
Conflicts of Interest and Spin in Reviews of Psychological Therapies: A Systematic Review
- Klaus Lieb, Jan von der Osten-Sacken, Jutta Stoffers-Winterling, Neele Reiss and Jürgen Barth
- BMJ Open
- Published in 2016
